Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : All Clowns Must Be Destroyed -- Ignore unavailable to you. Want to Upgrade?

To: pater tenebrarum who wrote (3801)	1/24/2000 6:00:00 PM
From: Lucretius	Read Replies (2) \| Respond to of 42523

yep... ain't gonna be pretty.. where do you see support?

To: pater tenebrarum who wrote (3801)	1/24/2000 11:32:00 PM
From: Lucretius	Read Replies (2) \| Respond to of 42523

ho ho "The market did have a decent tone [earlier] but there was heavier profit-taking than people thought we'd see," said Jim Volk, co-director of institutional trading at D.A. Davidson in Portland. "People were running to the hills on stuff previously parabolic." For example, the trader noted Enzo Biochem (ENZ:NYSE - news) -- a huge winner last week -- declined 35% to 79 1/2 after trading as high as 139 intraday. But "this doesn't seal the end of the bull market," Volk continued. "I keep reminding myself the violence is compressed. It could be we completed a week's worth of selloff in a day. I still maintain it's a midcourse correction and not the beginning of a top." WRONGO, Clowno... -g-